Turkish Journal of Hematology Volume: 33 - Issue: 4
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Turk J Hematol 2016;<strong>33</strong>:311-319<br />
Çalık Başaran N, et al: Infection Episodes in Cancer Patients<br />
bacteremia in hospitalized cancer patients with febrile neutropenia: a<br />
cohort study. Am J Infect Control 2014;42:74-76.<br />
34. Anatoliotaki M, Valatas V, Mantadakis E, Apostolakou H, Mavroudis D,<br />
Georgoulias V, Rolston KV, Kontoyiannis DP, Galanakis E, Samonis G.<br />
Bloodstream infections in patients with solid tumors: associated factors,<br />
microbial spectrum and outcome. Infection 2004;32:65-71.<br />
35. Mrázová-Studená M, Drgona L, Spánik S, Krúpová I, Baláz M, Pichna P, Koren<br />
P, Sufliarsky J, Mardiak J, Kunová A, Trupl J, Krcméry V Jr. Bacteremia in<br />
neutropenic versus nonneutropenic cancer patients: etiology and outcome<br />
in 401 episodes. Neoplasma 1997;44:314-318.<br />
36. Velasco E, Byington R, Martins CA, Schirmer M, Dias LM, Goncalves VM.<br />
Comparative study <strong>of</strong> clinical characteristics <strong>of</strong> neutropenic and nonneutropenic<br />
adult cancer patients with bloodstream infections. Eur J Clin<br />
Microbiol Infect Dis 2006;25:1-7.<br />
37. Marin M, Gudiol C, Ardanuy C, Garcia-Vidal C, Jimenez L, Domingo-<br />
Domenech E, Perez FJ, Carratala J. Factors influencing mortality in<br />
neutropenic patients with haematologic malignancies or solid tumours<br />
with bloodstream infection. Clin Microbiol Infect 2015;21:583-590.<br />
38. Marin M, Gudiol C, Garcia-Vidal C, Ardanuy C, Carratala J. Bloodstream<br />
infections in patients with solid tumors: epidemiology, antibiotic therapy,<br />
and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore)<br />
2014;93:143-149.<br />
39. Cornely OA, Gachot B, Akan H, Bassetti M, Uzun O, Kibbler C, Marchetti O, de<br />
Burghgraeve P, Ramadan S, Pylkkanen L, Ameye L, Paesmans M, Donnelly JP;<br />
EORTC Infectious Diseases Group. Epidemiology and outcome <strong>of</strong> fungemia<br />
in a cancer cohort <strong>of</strong> the Infectious Diseases Group (IDG) <strong>of</strong> the European<br />
Organization for Research and Treatment <strong>of</strong> Cancer (EORTC 65031). Clin<br />
Infect Dis 2015;61:324-<strong>33</strong>1.<br />
40. Chan TS, Marcella SW, Gill H, Hwang YY, Kwong YL. Posaconazole versus<br />
fluconazole or itraconazole for prevention <strong>of</strong> invasive fungal diseases in<br />
patients with acute myeloid leukemia or myelodysplastic syndrome: a costeffectiveness<br />
analysis in an Asian teaching hospital. J Med Econ 2016;19:77-83.<br />
41. El-Cheikh J, Crocchiolo R, Vai A, Furst S, Bramanti S, Sarina B, Granata A,<br />
Faucher C, Mohty B, Harbi S, Bouabdallah R, Vey N, Santoro A, Chabannon<br />
C, Castagna L, Blaise D. Comparison <strong>of</strong> three distinct prophylactic<br />
agents against invasive fungal infections in patients undergoing haploidentical<br />
hematopoietic stem cell transplantation and post-transplant<br />
cyclophosphamide. Mediterr J Hematol Infect Dis 2015;7:e2015048.<br />
42. Bow EJ, Vanness DJ, Slavin M, Cordonnier C, Cornely OA, Marks DI, Pagliuca A,<br />
Solano C, Cragin L, Shaul AJ, Sorensen S, Chambers R, Kantecki M, Weinstein D,<br />
319